ATE289685T1 - Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben - Google Patents

Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben

Info

Publication number
ATE289685T1
ATE289685T1 AT03103218T AT03103218T ATE289685T1 AT E289685 T1 ATE289685 T1 AT E289685T1 AT 03103218 T AT03103218 T AT 03103218T AT 03103218 T AT03103218 T AT 03103218T AT E289685 T1 ATE289685 T1 AT E289685T1
Authority
AT
Austria
Prior art keywords
cervical
solubilized
carcinomas
body sample
overexpression
Prior art date
Application number
AT03103218T
Other languages
English (en)
Inventor
Ruediger Dr Ridder
Anja Dr Reichert
Matthias Dr Herkert
Knebel Doeberitz Magnus Dr Von
Original Assignee
Mtm Lab Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mtm Lab Ag filed Critical Mtm Lab Ag
Application granted granted Critical
Publication of ATE289685T1 publication Critical patent/ATE289685T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT03103218T 2003-08-25 2003-08-25 Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben ATE289685T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03103218A EP1507148B1 (de) 2003-08-25 2003-08-25 Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben

Publications (1)

Publication Number Publication Date
ATE289685T1 true ATE289685T1 (de) 2005-03-15

Family

ID=33560881

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03103218T ATE289685T1 (de) 2003-08-25 2003-08-25 Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
AT04104026T ATE461449T1 (de) 2003-08-25 2004-08-20 Verfahren zum nachweis von medizinisch relevanten zuständen in gelösten lbc-proben

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT04104026T ATE461449T1 (de) 2003-08-25 2004-08-20 Verfahren zum nachweis von medizinisch relevanten zuständen in gelösten lbc-proben

Country Status (13)

Country Link
US (1) US7932047B2 (de)
EP (2) EP1507148B1 (de)
JP (2) JP5619336B2 (de)
CN (1) CN1836166B (de)
AT (2) ATE289685T1 (de)
AU (1) AU2004317284B2 (de)
BR (1) BRPI0414030B8 (de)
CA (1) CA2528490C (de)
DE (2) DE60300339T2 (de)
ES (1) ES2342535T3 (de)
MX (1) MXPA05013903A (de)
RU (1) RU2405158C2 (de)
WO (2) WO2005088311A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601497B2 (en) 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
EP1510820B1 (de) * 2003-08-25 2010-03-17 MTM Laboratories AG Verfahren zum Nachweis von medizinisch relevanten Zuständen in gelösten LBC-Proben
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
CN101460636A (zh) * 2006-05-11 2009-06-17 伯克顿迪金森公司 从细胞中提取蛋白质的方法
US8865162B2 (en) * 2008-06-13 2014-10-21 Oncohealth Corp. Monoclonal antibodies against HPV proteins
WO2010129821A1 (en) * 2009-05-07 2010-11-11 Oncohealth Corporation Identification of high grade or ≥cin2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (hpv) and hpv-associated cancers
US8968995B2 (en) 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US9207240B2 (en) 2007-11-14 2015-12-08 Arbor Vita Corporation Method of efficient extraction of protein from cells
JP2011511271A (ja) 2008-01-25 2011-04-07 サイトテック ラブズ リミテッド ライアビリティ カンパニー 腫瘍原性、腫瘍進行、および処置効率の査定のためのアッセイシステム
US20090204009A1 (en) * 2008-02-07 2009-08-13 Los Alamos National Security Medical device system and related methods for diagnosing abnormal medical conditions based on in-vivo optical properties of tissue
US8728745B2 (en) 2008-09-04 2014-05-20 Ventana Medical Sysems, Inc. Method for prediction of the progression risk of tumors
JP2012506705A (ja) * 2008-10-27 2012-03-22 キアジェン ゲイサーズバーグ インコーポレイテッド 迅速に結果を得るハイブリッドキャプチャー法による分析およびシステム
CN101487845B (zh) * 2009-02-19 2013-01-02 苏州海路生物技术有限公司 大便标本自动检测仪
CN102414327B (zh) 2009-05-01 2015-04-08 奇亚根盖瑟斯堡股份有限公司 用于在样品中检测rna剪接形式的非靶向扩增方法
US9128094B2 (en) 2010-01-08 2015-09-08 Oncohealth Corp. High throughput cell-based HPV immunoassays for diagnosis and screening of HPV-associated cancers
JP6103941B2 (ja) 2010-01-29 2017-03-29 キアジェン ゲイサーズバーグ インコーポレイテッド 核酸の配列特異的精製および多重分析のための方法および組成物
JP2013517803A (ja) 2010-01-29 2013-05-20 キアジェン ゲイサーズバーグ インコーポレイテッド サンプル中のｈｐｖの存在を決定および確認する方法
CA2799200A1 (en) 2010-05-19 2011-11-24 Qiagen Gaithersburg, Inc. Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
US9376727B2 (en) 2010-05-25 2016-06-28 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically truncated probes
WO2011158847A1 (ja) * 2010-06-17 2011-12-22 国立大学法人 岡山大学 microRNA標的遺伝子検出用キット及びmicroRNA標的遺伝子の検出方法
GB201014335D0 (en) * 2010-08-27 2010-10-13 Forensic Science Service Ltd Improvements in and relating to analysis
BR112013005116A2 (pt) 2010-09-03 2019-09-24 Stem Centrx Inc moduladores e métodos de uso
CN102033056B (zh) * 2010-10-14 2012-05-30 中国科学院化学研究所 抑制膜蛋白受体聚集的抗癌药物鉴定方法
WO2012116220A2 (en) 2011-02-24 2012-08-30 Qiagen Gaithersburg, Inc. Materials and methods for detection of hpv nucleic acid
AU2012340441A1 (en) 2011-11-15 2014-05-29 University Of Miami Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma
RU2508542C1 (ru) * 2012-07-16 2014-02-27 Полина Михайловна Шварцбурд Экспресс-способ определения риска злокачественности клеток
RU2535071C1 (ru) * 2013-04-09 2014-12-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия" Министерства здравоохранения Российской Федерации Способ диагностики недифференцированной дисплазии соединительной ткани у женщин с потерей беременности в анамнезе
RU2016104892A (ru) * 2013-07-31 2017-09-04 Юнивёрсити Оф Майями Композиции и способы для идентификации риска развития ракового заболевания у субъекта
WO2015147370A1 (en) * 2014-03-28 2015-10-01 Seegene, Inc. Detection of target nucleic acid sequences using different detection temperatures
RU2558987C1 (ru) * 2014-04-21 2015-08-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ диагностики степени тяжести недифференцированной дисплазии соединительной ткани у женщин репродуктивного возраста
JP6854246B2 (ja) 2015-06-08 2021-04-07 アーケア ダイアグノスティクス リミテッド 尿サンプルの分析方法
EP4060344A1 (de) 2015-06-08 2022-09-21 Arquer Diagnostics Limited Verfahren und kits
CN106610434A (zh) * 2016-02-26 2017-05-03 弗雷米德生物医药技术（天津）有限公司 一种hpv16型e7蛋白的elisa检测试剂盒
RU2680930C2 (ru) * 2017-03-24 2019-02-28 федеральное государственное бюджетное образовательное учреждение высшего образования "Северный государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ забора материала для цитологического исследования при опухолевых заболеваниях поджелудочной железы, печени и желчевыводящих путей
CN107748265A (zh) * 2017-09-29 2018-03-02 中南大学湘雅医院 Cdc6和ki67在制备癌症放疗抵抗的诊断标记物中的应用
EP3732301A4 (de) * 2017-12-29 2022-02-09 Vertex Pharmaceuticals Incorporated Verfahren zur krebsbehandlung unter verwendung eines atr-inhibitors
US11230729B2 (en) 2018-04-20 2022-01-25 Inanna Diagnostics, Inc Methods and devices for obtaining cellular and DNA material from human female reproductive system
CN109781977B (zh) * 2019-01-09 2022-03-29 首都医科大学附属北京安定医院 IL15Rα以及相关膜蛋白检测试剂盒及其应用
RU2707099C1 (ru) * 2019-04-24 2019-11-22 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации Способ скрининга злокачественных опухолей органов грудной полости
MX380106B (es) * 2019-05-21 2025-03-12 Timser S A P I De C V Biomarcadores relacionados a cancer.
CN117233382A (zh) * 2023-09-08 2023-12-15 江苏默乐生物科技股份有限公司 一种可同时检测低危型和高危型人乳头瘤病毒的抗原检测试剂盒及其应用
CN119639903B (zh) * 2025-01-17 2025-11-25 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 用于肝内胆管癌的生物标记物、药物及其应用
CN121208346A (zh) * 2025-11-25 2025-12-26 长兴固容生物科技有限公司 一种用于宫颈癌筛查、诊断的标志物组及其用途

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
WO1992020796A2 (en) 1991-05-16 1992-11-26 Cold Spring Harbor Laboratory D-type cyclin and uses related thereto
US5889169A (en) 1991-05-16 1999-03-30 Cold Spring Harbor Laboratory Cell cycle regulatory protein p16 gene
CA2125769C (en) 1991-12-13 1999-01-26 Morgan Van Aken Agglutination assays and kits employing colloidal dyes
US6316208B1 (en) 1994-01-07 2001-11-13 Memorial Sloan-Kettering Cancer Center Methods for determining isolated p27 protein levels and uses thereof
CN1128049A (zh) 1994-03-18 1996-07-31 犹他大学研究基金会 多肿瘤抑制因子基因种系突变及检测该基因癌肿倾向性的方法
US6060301A (en) 1994-03-18 2000-05-09 Myriad Genetics, Inc. Vector containing MTS1E1β gene
US5989815A (en) 1994-03-18 1999-11-23 University Of Utah Research Foundation Methods for detecting predisposition to cancer at the MTS gene
CA2164167A1 (en) 1994-12-20 1996-06-21 Izak Bahar Assay normalization method
US6033847A (en) 1995-02-06 2000-03-07 St. Jude Children's Research Hospital InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
US5843756A (en) 1995-06-07 1998-12-01 Myriad Genetics, Inc. Mouse MTSI gene
US6403383B1 (en) 1996-03-11 2002-06-11 American Bio Medica Corp. Diagnostic test kit for immunological assays of fluid samples
US5976799A (en) 1996-03-21 1999-11-02 The Board Of Trustees Of The University Of Arkansas Early detection of ovarian carcinoma using P16 gene products
US5955268A (en) * 1996-04-26 1999-09-21 Abbott Laboratories Method and reagent for detecting multiple nucleic acid sequences in a test sample
US5858683A (en) 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
US6180333B1 (en) * 1997-05-15 2001-01-30 Thomas Jefferson University Determination of cyclin-dependent kinase inhibitor P27 levels as a prognostic factor in cancer patients
WO1999004238A2 (en) 1997-07-15 1999-01-28 Mitotix, Inc. Reagents and methods for diagnosis and prognosis of proliferative disorders
US6090579A (en) 1997-08-12 2000-07-18 Smithkline Beecham Corporation Human SDR2 cDNA clone
PT1038022E (pt) 1997-12-12 2005-11-30 Digene Corp Avaliacao de doencas relacionadas com o virus papiloma humano
US20010051364A1 (en) 1997-12-23 2001-12-13 Francis Michon Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines
US6686151B1 (en) 1998-02-06 2004-02-03 Digene Corporation Immunological detection of RNA:DNA hybrids on microarrays
US7399589B2 (en) 1998-02-06 2008-07-15 Digene Corporation Immunological detection of RNA:DNA hybrids on microarrays
US5994079A (en) 1998-02-06 1999-11-30 Digene Corporation Direct detection of RNA mediated by reverse transcriptase lacking RNAse H function
US6576420B1 (en) 1998-06-23 2003-06-10 Regents Of The University Of California Method for early diagnosis of, and determination of prognosis in, cancer
DE19829473C2 (de) 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
US7306926B2 (en) 1998-07-01 2007-12-11 Mtm Laboratories Ag Method for detecting carcinomas in a solubilized cervical body sample
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
WO2000031538A1 (en) * 1998-11-23 2000-06-02 Praxsys Biosystems, Inc. Improved lateral flow assays
SE515668C2 (sv) * 1999-02-22 2001-09-17 Quantovir Ab Metod och kit för tidig förutsägelse av cancer
DE10014685B4 (de) 2000-03-24 2004-07-01 Schubert, Walter, Dr. Verfahren zur Identifizierung von zellspezifischen Zielstrukturen
GB0018140D0 (en) 2000-07-24 2000-09-13 Medical Res Council Screening for abnormalities
DE10063179A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
ITRM20010363A1 (it) * 2001-06-25 2001-09-24 Franco Castelmani Gancio adattivo applicato ad un generatore di vivrazioni sinusoidali.
EP2272988A3 (de) * 2002-01-07 2011-06-15 Norchip A/S Detektionsverfahren für papillomavirus mRNA
EP1333278B1 (de) 2002-02-01 2004-03-10 MTM molecular tools in medicine Verfahren zur Prognose gastrointestinaler Tumoren
DK1388734T3 (da) 2002-08-01 2004-05-03 Mtm Lab Ag Metode til opløsningsbaseret diagnose
US7361460B2 (en) 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases

Also Published As

Publication number Publication date
CA2528490C (en) 2015-11-03
BRPI0414030B8 (pt) 2021-07-27
JP5619336B2 (ja) 2014-11-05
CN1836166B (zh) 2010-05-26
AU2004317284A1 (en) 2005-09-22
RU2405158C2 (ru) 2010-11-27
CN1836166A (zh) 2006-09-20
JP5677270B2 (ja) 2015-02-25
JP2012032412A (ja) 2012-02-16
DE60300339D1 (de) 2005-03-31
ATE461449T1 (de) 2010-04-15
US7932047B2 (en) 2011-04-26
AU2004317284B2 (en) 2009-11-05
HK1092219A1 (zh) 2007-02-02
WO2005084103A2 (en) 2005-09-15
EP1507148A1 (de) 2005-02-16
CA2528490A1 (en) 2005-09-22
DE60300339T2 (de) 2006-04-13
ES2342535T3 (es) 2010-07-08
DE602004026014D1 (de) 2010-04-29
EP1507148B1 (de) 2005-02-23
US20070190529A1 (en) 2007-08-16
EP1664788A1 (de) 2006-06-07
WO2005088311A1 (en) 2005-09-22
BRPI0414030B1 (pt) 2017-04-04
JP2007503208A (ja) 2007-02-22
MXPA05013903A (es) 2006-03-09
RU2006101395A (ru) 2006-06-10
BRPI0414030A (pt) 2007-01-23

Similar Documents

Publication Publication Date Title
ATE289685T1 (de) Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
PH12020551371A1 (en) Assays to detect neurodegeneration
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
MX2007005053A (es) Metodo para evaluar la enfermedad de alzheimer y reactivo de diagnostico.
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
MY145455A (en) Diagnostic biomolecule(s)
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
SI1977244T1 (sl) Razlikovanje med bakterijskim meningitisom in virusnim meningitisom
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
EP1636587A4 (de) Einen für menschliches protoonkogenes protein spezifischen antikörper enthaltender diagnostischer kit für leberzirrhose
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein
WO2009016734A1 (ja) 軽度認知機能障害の検定方法
ATA19972000A (de) Pibf für die diagnose von tumoren
EA201001340A1 (ru) Улучшенный аналитический способ для определения латентного гепатита с, его применения и соответствующий диагностический набор
WO2006112962A3 (en) Syphilis diagnostic test and kits
DE602004017017D1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome
WO2005040807A3 (en) Swiprosin-2 as a breast cancer marker
SG152020A1 (en) Diagnostic methods
WO2003005033A8 (en) Carcinoma-related peptides
WO2005124354A3 (en) Use of protein ch10 as a marker for breast cancer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties